Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its FcγRIIIA

Mass Spectrometry Data Intact Mass Specs : 1) <strong>Commercial Syn :</strong> <strong>20220404_Grayson_I01</strong>.raw 2)<strong> Syn-GnF</strong> : <strong>20220404_Grayson_I07</strong>.raw 3) <strong>Syn-Gn</strong> : <strong>20220404_Grayson_I02</strong>.raw 4) <strong>Syn-G0</strong> : <strong>20220404_Grayson_I03</strong>.raw 5) <strong>Syn-G1(3)</strong> : <strong>20220404_Grayson_I04</strong>.raw<strong> </strong> 6) <strong>Syn G1(6):</strong> <strong>20210329_Grayson_17</strong>.raw 7) <strong>Syn G2</strong> : <strong>20210329_Grayson_08</strong>.raw <br> Glycan MS/MS (G1(3)T, G1(6)T): <br> 8) <strong>20201013_11_Roger_G1_6_T.</strong> raw 9) <strong>20201013_08_Roger_G1_3_T</strong>.raw <br>